Restart Life Science: Funding, Investors & Team (Sep 2026)
Restart Life Science is a research and development-driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes.
Restart Life Science has raised $70k across 1 funding round on record, the most recent an undisclosed round of $70k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Restart Life Science Company Profile and Key Stats
Latest funding round on record: May 2026.
Restart Life Science Funding Rounds
Restart Life Science Founders and Leadership Team
Contact details for the Restart Life Science team: 1 has a LinkedIn profile.
Start 14-day free trial →Restart Life Science Funding Compared to Other Biotechnology Startups
Restart Life Science's latest round of $70k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Restart Life Science in Biotechnology and Vancouver
Companies Similar to Restart Life Science
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Restart Life Science Funding FAQs
What does Restart Life Science do?
Restart Life Science is a research and development-driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes.
How much funding has Restart Life Science raised?
Restart Life Science has raised $70k across 1 round on record. The most recent is an undisclosed round of $70k announced in May 2026.
When did Restart Life Science last raise funding?
Restart Life Science's most recent funding round on record is an undisclosed round of $70k, announced in May 2026.
Who founded Restart Life Science?
FundedIQ lists Steve Loutskou (Founder) at Restart Life Science.
Where is Restart Life Science headquartered?
Restart Life Science is based in Vancouver, British Columbia, Canada.
How many employees does Restart Life Science have?
Restart Life Science is in the 1-10 employee band.
How does Restart Life Science's funding compare to other Biotechnology startups?
Restart Life Science's latest round of $70k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Restart Life Science Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Restart Life Science is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.